Glycine intrastriatal administration induces lipid and protein oxidative damage and alters the enzymatic antioxidant defenses in rat brain

Life Sciences

Volumn 89, Issue 7-8, 2011, Pages 276-281

  Seminotti, Bianca ^a   Knebel, Lisiane Aurélio ^a   Fernandes, Carolina Gonçalves ^a   Amaral, Alexandre Umpierrez ^a   Da Rosa, Mateus Struecker ^a   Eichler, Paula ^a   Leipnitz, Guilhian ^a   Wajner, Moacir ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Glycine; Nonketotic hyperglycinemia; Oxidative stress; Rat striatum

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; IN VIVO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT;

ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GLYCINE; GLYCINE AGENTS; HYPERGLYCINEMIA, NONKETOTIC; LIPID PEROXIDATION; MICROINJECTIONS; NEUROPROTECTIVE AGENTS; OXIDOREDUCTASES; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 79960978441     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.06.013     Document Type: Article

References (48)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
2. Aksenov MY, Markesbery WR. Change in thiol content and expression of glutathione redox system gene in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 2001;302:141-5. (Pubitemid 32274229)
3. Applegarth DA, Toone JR. Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Mol Genet Metab 2001;74:139-46. (Pubitemid 32955155)
4. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia 1969-1996. Pediatrics 2000:105-10.
5. Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Method Mol Cell Biol 1998;108:347-52.
6. Busanello ENB, Moura AP, Viegas CM, Zanatta A, da Costa Ferreira G, Schuck PF, et al. Neurochemical evidence that glycine induces bioenergetical dysfunction. Neurochem Int 2010;56:948-54.
7. Calberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-90. (Pubitemid 16195819)
8. Cherian A, Thomas B, Baheti NN, Chemmanam T, Kesavadas C. Concepts and controversies in nonketotic hyperglycemia-induced hemichorea: further evidence from susceptibility-weighted MR imaging. J Magn Reson Imaging 2009;29:699-703.
9. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169-76. (Pubitemid 36626706)
10. Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001;388:261-6. (Pubitemid 32911618)
11. Fridovich I. Superoxide dismutases. J Biol Chem 1989;264:7761-4.
12. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-23.
13. Halliwell B, Gutteridge JMC. Measurement of reactive species. In: Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine. 4th ed. Oxford: Oxford University Press; 2007. p. 268-340.
14. Hamosh A, Johnston MV. Non-ketotic hyperglycinemia. In: Scriver CR, Beaudet A, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. NewYork: McGraw-Hill; 2001. p. 2065-78.
15. Hansen RE, Roth D, Winther JR. Quantifying the global cellular thiol-disulfide status. Proc Natl Acad Sci USA 2009;106:422-7.
16. Hara H, Sukamoto T, Kogure K. Mechanism and pathogenesis of ischemia induced neuronal damage. Prog Neurobiol 1993;40:645-70. (Pubitemid 23094669)
17. Jara-Prado A, Ortega-Vazquez A, Martinez-Ruano L, Rios C, Santamaria A. Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox Res 2003;5:237-43.
18. Katsuki H, Watanabe Y, Fujimoto S, Kume T, Akaike A. Contribution of endogenous glycine and D-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures. Life Sci 2007;81:740-9. (Pubitemid 47285193)
19. Kikuchi G, Motokawa Y, Yoshida T, Hiraga K. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci 2008;84:246-63.
20. Kono Y, Shigetomi E, Inoue K, Kato F. Facilitation of spontaneous glycine release by anoxia potentiates NMDA receptor current in the hypoglossal motor neurons of the rat. Eur J Neurosci 2007;25:1748-56. (Pubitemid 46550002)
21. Korman SH, Wexler ID, Gutman A, Rolland MO, Kanno J, Kure S. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation. Ann Neurol 2006;59:411-5. (Pubitemid 43202501)
22. Kure S, Tada K, Narisawa K. Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects. Jpn J Hum Genet 1997;42:13-22. (Pubitemid 27212904)
23. Lakshminarayanan V, Drab-Weiss EA, Roebuck KA. H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998;273:32670-8. (Pubitemid 28557650)
24. Leipnitz G, Solano AF, Seminotti B, Amaral AU, Fernandes CG, Beskow AP, et al. Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats. Cell Mol Neurobiol 2009;29:253-61.
25. Leon SF, Clark JB. Regional development of glutamate dehydrogenase in the rat brain. J Neurochem 1984;43:106-11. (Pubitemid 14083322)
26. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-57.
27. Lissi E, Salim-Hanna M, Pascual C, del Castillo MD. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 1995;18:153-8.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
29. Marklund SL. Pyrogallol autoxidation. Handbook for oxygen radical research. Boca Raton, FL: CRC Press; 1985. p. 243-7.
30. Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999;32:595-603.
31. McNamara D, Dingledine R. Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. J Neurosci Res 1990;10:3970-6.
32. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71. (Pubitemid 34146173)
33. Obrenovitcha TP, Hardya AM, Urenjak J. High extracellular glycine does not potentiate N-methyl-D-aspartate-evoked depolarization in vivo. Brain Res 1997;746:190-4. (Pubitemid 27060347)
34. Patel J, Zinkand WC, Thompson C, Keith R, Salama A. Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 1990;54:849-54.
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press; 1986.
36. Press GA, Barshop BA, Haas RH, Nyhan WL, Glass RF, Hesselink JR. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR Am J Neuroradiol 1989;10:315-21. (Pubitemid 19082621)
37. Requejo R, Hurd TR, Costa NJ, Murphy MP. Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage. FEBS J 2010;277:1465-80.
38. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
39. Ribeiro CA, Grando V, Dutra Filho CS, Wannmacher CM, Wajner M. Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats. J Neurochem 2006;99:1531-42. (Pubitemid 44924231)
40. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991;266:11632-9. (Pubitemid 21906996)
41. Santamaría A, Ríos C. MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 1993;159:51-4. (Pubitemid 23283236)
42. Shan DE. An explanation for putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia. AJNR Am J Neuroradiol 2005;26:194-5.
43. Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991;266:24398-403. (Pubitemid 21908955)
44. Singh P, Jain A, Kaur G. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 2004;260:153-9. (Pubitemid 39127583)
45. Thomas JA, Poland B, Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 1995;319:1-9.
46. Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325-32.
47. Wintermark M, Fischbein NJ, Mukherjee P, Yuh EL, Dillon WP. Unilateral putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia in the setting of acute neurologic symptomsmimicking stroke.AJNRAmJNeuroradiol 2004;25:975-6.
48. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998;108:107-10.